Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... showing much lower rates for adjunctive stenting (5 percent vs. 45 percent) and restenosis (15 percent vs. 62.5 percent). CSI is advancing several clinical studies. ...
2009 NOV 9 ... Gastroenterology, Heart Disease, Pharmaceuticals, Pharmacological, Progenitor Cell, Restenosis, Stem Cell Research, Thrombosis, University of Sydney. This article was ...
2009 NOV 16 ... therapy for ostial atherosclerotic renal artery stenosis, can be complicated by in-stent restenosis weeks to months after the procedure." "There is currently no consensus ...
2009 NOV 9 ... "The remodeled vessel wall in many vascular diseases such as restenosis after injury is characterized by proliferative and apoptosis-resistant vascular smooth ...
2009 NOV 9 ... = 0.74) or definite stent thrombosis (ST) (RR 0.50, 95% CI 0.19 to 1.32, p = 0.16). The restenosis risk of MV and SB did not differ between the simple strategy group and the complex ...
2009 NOV 16 ... "Neointimal hyperplasia contributes to atherosclerosis and restenosis after percutaneous coronary intervention. Vascular injury in each of these conditions ...
2009 NOV 9 ... The researchers concluded: "PAI-1-R has therapeutic potential to inhibit vascular restenosis without promoting thrombosis. (Arterioscler Thromb Vasc Biol. 2009; 29:1565-1570.)." ...
2009 NOV 16 ... "Therefore, it is important to determine the factors associated with post-SES restenosis. The study investigated 341 patients with angina pectoris, in whom SES was implanted. ...
2009 NOV 9 ... wound healing, but it has also been implicated in the pathogenesis of atherosclerosis, restenosis, posttransplant arteriopathy, and pulmonary hypertension," investigators in the United ...
2009 NOV 23 ... of coronary artery disease, a ''pro-healing'' approach for prevention of in-stent restenosis and late stent thrombosis is intuitively favored over the use of cytotoxic or cytostatic ...
2009 NOV 9 ... device. We also filed a 510k application with the FDA for the treatment of in-stent restenosis in leg arteries. During the quarter, we completed a restructuring of the Company's ...
2009 NOV 9 ... suggests that LA may have therapeutic effects in the prevention of atherosclerosis, restenosis and neointimal hyperplasia." Chen and colleagues published their study in ...
2009 NOV 23 ... "Intimal hyperplasia is a major cause of restenosis after the interventional or surgical treatment of occlusive arterial disease. We ...
2009 NOV 9 ... "To test for an association with risk for restenosis after coronary stent placement, the TNF-alpha and IL-10 polymorphisms were analyzed by ...
2009 NOV 23 ... with iliac occlusive disease. The data showed a statistically significant difference in restenosis and freedom from occlusion rates when using the Advanta V12 versus a BMS. ...
